Zenapax Alternatives Compared
| Zenapax (daclizumab) | Tacrolimus | CellCept (mycophenolate mofetil) |
|
|---|
| Zenapax (daclizumab) | Tacrolimus | CellCept (mycophenolate mofetil) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Organ Transplant - Rejection Prophylaxis. Zenapax may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Organ Transplant - Rejection Reversal, Nephrotic Syndrome, Graft Versus Host Disease, Organ Transplant - Rejection Prophylaxis, Crohn's Disease. Tacrolimus may also be used for... View more |
Prescription only
Prescribed for Organ Transplant - Rejection Prophylaxis. CellCept may also be used for purposes not listed in this medication guide. |
Related suggestions Organ Transplant, Rejection Prophylaxis
|
|||||||||||||||
| More about (daclizumab) | More about Tacrolimus | More about CellCept (mycophenolate mofetil) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Be the first to share your experience with this drug. |
Tacrolimus has an average rating of 8.1 out of 10 from a total of 48 ratings on Drugs.com. 76% of reviewers reported a positive effect, while 10% reported a negative effect. |
CellCept has an average rating of 8.3 out of 10 from a total of 35 ratings on Drugs.com. 76% of reviewers reported a positive effect, while 6% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Tacrolimus prices |
View all CellCept prices |
||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
|
N/A |
Astagraf XL, Envarsus XR, Prograf | Other mycophenolate mofetil brands include: Myhibbin | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
480 hours |
21.2 hours |
18 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 457 drugs are known to interact with Zenapax:
|
A total of 848 drugs are known to interact with Tacrolimus:
|
A total of 337 drugs are known to interact with CellCept:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
April 08, 1994 |
May 03, 1995 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Professional Resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.